Provider
P58-20 Hereditary Angioedema (HAE) Drug Prior Authorization Management Changes for generic Icatibant, Firazyr, Haegarda, and Takhzyro — Effective October 5, 2020
Program effective Date: Aug 03, 2020
Program effective Date: Aug 03, 2020
Program effective Date: Aug 03, 2020
Program effective Date: May 01, 2020
Program effective Date: May 01, 2020
Program effective Date: Apr 22, 2020
Program effective Date: Apr 22, 2020
Program effective Date: Apr 08, 2020
Program effective Date: Apr 08, 2020
Program effective Date: Apr 08, 2020